Ruby Prosser Scully

1 week ago | dermatologyrepublic.com.au | Ruby Prosser Scully

More people than ever are misusing topical corticosteroids, prompting warnings about wide-reaching potential harms. Experts are warning about the growing number of people using skin bleaching products globally, and Australians could be at risk of products brought in from overseas. The International League of Dermatological Societies released a position paper on 31 March warning about the harms of misusing topical corticosteroids.

1 week ago | dermatologyrepublic.com.au | Ruby Prosser Scully

Patients are increasingly seeking alternatives to long-term antibiotics for acne. Safety concerns have been raised in the wake of growing popularity of spironolactone for acne among young women and girls in the US, although an Australian expert says the drug has been well-tolerated in its long history of use here.

2 weeks ago | puffnstuff.com.au | Ruby Prosser Scully

A personalised elimination diet, guided by IgG, reduced abdominal pain over a two-month study. More than half of patients with irritable bowel syndrome had a drop in abdominal pain if they followed an IgG-guided elimination diet, which was significantly better than those in the sham treatment. The researchers randomly assigned more than 200 IBS patients across eight US centres to receive either the experimental antibody-guided diet or a sham diet for two months.

3 weeks ago | medicalrepublic.com.au | Ruby Prosser Scully

A personalised elimination diet, guided by IgG, reduced abdominal pain over a two-month study. More than half of patients with irritable bowel syndrome had a drop in abdominal pain if they followed an IgG-guided elimination diet, which was significantly better than those in the sham treatment. The researchers randomly assigned more than 200 IBS patients across eight US centres to receive either the experimental antibody-guided diet or a sham diet for two months.

3 weeks ago | medicalrepublic.com.au | Ruby Prosser Scully

Cutting antibiotics may reduce the chance of antimicrobial resistance, while also lowering side effects and costs for patients. Low-dose minocycline hydrochloride is better than doxycycline for treating moderate to severe rosacea, according to two new phase 3 trials.